Drugs / Rivoroxaban
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03191305 Comparator | Aug 2017 → Sep 2018 | cerebral sinovenous thrombosis | Foundation University Islamabad | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rivoroxaban | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03191305 ↗ |
| Route | Oral | “15 mg PO q12hr for 21 days with food, Then 20 mg PO qDay for 6 months.” NCT03191305 ↗ |